Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Bristol-Myers Squibb Co shares valued at $3,702 were sold by Hickey Benjamin on May 09 ’25. At $38.01 per share, Hickey Benjamin sold 97 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
Also, Hirawat Samit purchased 4,250 shares, netting a total of over 202,215 in proceeds. Following the buying of shares at $47.58 each, the insider now holds 83,513 shares.
Before that, BOERNER CHRISTOPHER S. had added 2,000 shares to its account. In a trade valued at $110,096, the Chief Executive Officer bought Bristol-Myers Squibb Co shares for $55.05 each. Upon closing the transaction, the insider’s holdings increased to 2,000 shares, worth approximately $4.88 million.
As published in their initiating research note from Piper Sandler on April 22, 2025, Bristol-Myers Squibb Co [BMY] has been an Overweight. Analysts at Cantor Fitzgerald started covering the stock with ‘”a Neutral”‘ outlook in a report released in late April. As of December 16, 2024, Jefferies has increased its “Hold” rating to a “Buy” for BMY.
Analyzing BMY Stock Performance
On last trading session,, Bristol-Myers Squibb Co [NYSE: BMY] plunged -0.74% to $46.68. The stock’s lowest price that day was $46.47, but it reached a high of $47.0 in the same session. During the last five days, there has been a drop of approximately -1.16%. Over the course of the year, Bristol-Myers Squibb Co shares have jumped approximately 11.33%. Shares of the company reached a 52-week high of $63.33 on 03/11/25 and a 52-week low of $44.00 on 05/14/25.
Support And Resistance Levels for Bristol-Myers Squibb Co (BMY)
According to the 24-hour chart, there is a support level at 46.43, which, if violated, would cause prices to drop to 46.19. In the upper region, resistance lies at 46.96. The next price resistance is at 47.25. RSI (Relative Strength Index) is 40.07 on the 14-day chart, showing neutral technical sentiment.
Is Bristol-Myers Squibb Co subject to short interest?
Stocks of Bristol-Myers Squibb Co saw a sharp steep in short interest on 2025-05-30 dropping by -4.58 million shares to 32.54 million. Data from Yahoo Finance shows that the short interest on 2025-04-30 was 37.12 million shares. A decline of -14.07% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 2.06 of the overall float, the days-to-cover ratio (short ratio) decline to 2.06.
Which companies own the most shares of Bristol-Myers Squibb Co (BMY)?
In terms of Bristol-Myers Squibb Co share price expectations, FactSet research, analysts set an average price target of 66.5 in the next 12 months, up nearly 41.4% from the previous closing price of $47.03. Analysts anticipate Bristol-Myers Squibb Co stock to reach 68 by 2025, with the lowest price target being 65. In spite of this, 14 analysts ranked Bristol-Myers Squibb Co stock as Hold at the end of 2025.
